![Ray Takigiku](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ray Takigiku active positions
Companies | Position | Start | End |
---|---|---|---|
Bexion Pharmaceuticals, Inc.
![]() Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | Chief Tech/Sci/R&D Officer | 02/02/2022 | - |
Founder | 01/01/2006 | - | |
Director/Board Member | 01/01/2006 | - | |
Chief Executive Officer | 01/01/2006 | 02/02/2022 | |
President | 01/01/2006 | 02/02/2022 | |
Sidis Corp
![]() Sidis Corp Financial ConglomeratesFinance Sidis Corp provides investment services for market-leading life science companies. | Director/Board Member | - | - |
Career history of Ray Takigiku
Statistics
International
United States | 3 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Commercial Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Bexion Pharmaceuticals, Inc.
![]() Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | Commercial Services |
Sidis Corp
![]() Sidis Corp Financial ConglomeratesFinance Sidis Corp provides investment services for market-leading life science companies. | Finance |
- Stock Market
- Insiders
- Ray Takigiku
- Experience